Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Carcinoma, Squamous Cell"" wg kryterium: Temat


Tytuł:
Neoadjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Borderline Resectable Esophageal Squamous Cell Carcinoma.
Autorzy:
Hosogi H; Department of Surgery, Japanese Red Cross Osaka Hospital, 5-30 Fudegasakicho, Tennoji Ward, Osaka, 543-8555, Japan. .
Yoshida S; Department of Surgery, Japanese Red Cross Osaka Hospital, 5-30 Fudegasakicho, Tennoji Ward, Osaka, 543-8555, Japan.
Sakaguchi M; Department of Surgery, Japanese Red Cross Osaka Hospital, 5-30 Fudegasakicho, Tennoji Ward, Osaka, 543-8555, Japan.; Department of Surgery, Kyoto City Hospital, Kyoto, Japan.
Kanaya S; Department of Surgery, Japanese Red Cross Osaka Hospital, 5-30 Fudegasakicho, Tennoji Ward, Osaka, 543-8555, Japan.
Pokaż więcej
Źródło:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2023 Dec; Vol. 27 (12), pp. 3040-3042. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/surgery
Esophageal Neoplasms*/pathology
Carcinoma, Squamous Cell*/therapy
Carcinoma, Squamous Cell*/pathology
Humans ; Neoadjuvant Therapy ; Esophagectomy ; Chemoradiotherapy ; Retrospective Studies ; Minimally Invasive Surgical Procedures
Czasopismo naukowe
Tytuł:
Association of preoperative muscle-adipose index measured by computed tomography with survival in patients with esophageal squamous cell carcinoma.
Autorzy:
Qian D; Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, People's Republic of China.
Shen P; Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, People's Republic of China.
Zhu J; Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, People's Republic of China.
Ji S; Department of Radiotherapy and Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, 215000, People's Republic of China. .
Kong Y; Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, People's Republic of China. ky_.
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Feb 22; Vol. 22 (1), pp. 61. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/surgery
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/surgery
Carcinoma, Squamous Cell*/diagnostic imaging
Carcinoma, Squamous Cell*/surgery
Humans ; Retrospective Studies ; Prognosis ; Obesity ; Muscles/pathology ; Tomography
Czasopismo naukowe
Tytuł:
Intralesional interferon alpha-2b as a novel treatment for periocular squamous cell carcinoma in horses.
Autorzy:
Martabano BB; Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Dow S; Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Chow L; Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Williams MMV; Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Mack MK; Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Bellone R; Veterinary Genetics Laboratory and Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, California, United States of America.
Wotman KL; Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 21; Vol. 19 (2), pp. e0297366. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Conjunctival Neoplasms*
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/veterinary
Carcinoma, Squamous Cell*/chemically induced
Horses ; Humans ; Animals ; Interferon alpha-2/therapeutic use ; Prospective Studies ; Interferon-alpha ; Antibodies/therapeutic use ; Recombinant Proteins
Czasopismo naukowe
Tytuł:
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome.
Autorzy:
Broghammer F; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Korovina I; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
Gouda M; Department of Otorhinolaryngology, Head and Neck Surgery, Ludwigs-Maximilians-University University Hospital, 81377, Munich, Germany.
Celotti M; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 3584 CT, Utrecht, the Netherlands.
van Es J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 3584 CT, Utrecht, the Netherlands.
Lange I; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Brunner C; Department of Otorhinolaryngology, Ulm University Medical Center, 89075, Ulm, Germany.
Mircetic J; German Cancer Consortium, Partner Site Dresden: German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Mildred Scheel Early Career Center (MSNZ) P2, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Coppes RP; Department of Biomedical Sciences of Cells and Systems, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, 9713, Groningen, The Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, 9713, Groningen, The Netherlands.
Gires O; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
Dahl A; DRESDEN-Concept Genome Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Dresden, Germany.
Seifert M; Institute for Medical Informatics and Biometry (IMB), Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), 69192, Heidelberg, Germany.
Cordes N; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany. .; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany. .; German Cancer Consortium, Partner Site Dresden: German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. .; National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), 69192, Heidelberg, Germany. .; Department of Radiotherapy and Radiation Oncology, University Hospital Carl Gustav Carus, 01307, Dresden, Germany. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Feb 21; Vol. 23 (1), pp. 39. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Antineoplastic Agents*/therapeutic use
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Integrin beta1/genetics ; Cell Line, Tumor ; Receptor Protein-Tyrosine Kinases/genetics ; ErbB Receptors/metabolism ; Phenotype ; Epithelial-Mesenchymal Transition/genetics
Czasopismo naukowe
Tytuł:
Sintilimab with two cycles of chemotherapy for the treatment of advanced squamous non-small cell lung cancer: a phase 2 clinical trial.
Autorzy:
Zhang M; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, 127 Dongming Rd, Zhengzhou, 450003, China.
Zhang G; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, 127 Dongming Rd, Zhengzhou, 450003, China.
Niu Y; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, 127 Dongming Rd, Zhengzhou, 450003, China.
Zhang G; Department of Medical Oncology, Xinxiang Central Hospital, 56 Jinsui Rd, Xinxiang, 453000, China.
Ji Y; Department of Medical Oncology, The First Affiliated Hospital of Xinxiang Medical University, 88 Jiankang Rd, Xinxiang, 453199, China.
Yan X; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, 127 Dongming Rd, Zhengzhou, 450003, China.
Zhang X; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, 127 Dongming Rd, Zhengzhou, 450003, China.
Wang Q; Department of Medical Oncology, The Second People's Hospital of Nanyang, 66 Jianshe Rd, Nanyang, 473000, China.
Jing X; Department of Medical Oncology, The First People's Hospital of Pingdingshan, 117 Youyue Rd, Pingdingshan, 467099, China.
Wang J; Department of Medical Oncology, Anyang Cancer Hospital, 2 N Huanbin Rd, Anyang, 455001, China.
Ma Z; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, 127 Dongming Rd, Zhengzhou, 450003, China.
Wang H; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, 127 Dongming Rd, Zhengzhou, 450003, China. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2024 Feb 19; Vol. 15 (1), pp. 1512. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Clinical Trial, Phase II; Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/chemically induced
Antibodies, Monoclonal, Humanized*
Humans ; Carboplatin/therapeutic use ; Carboplatin/adverse effects ; Paclitaxel/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Albumins
Czasopismo naukowe
Tytuł:
Genomic alterations in oral multiple primary cancers.
Autorzy:
Zhou X; Department of Oral Pathology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials, Beijing, China.; Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing, China.
Cai X; Department of Oral Pathology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials, Beijing, China.; Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing, China.
Jing F; Department of Oral Pathology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials, Beijing, China.; Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing, China.
Li X; Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China.
Zhang J; Department of Oral Pathology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials, Beijing, China.; Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing, China.
Zhang H; Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing, China. .; Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China. .
Li T; Department of Oral Pathology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials, Beijing, China. .; Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing, China. .
Pokaż więcej
Źródło:
International journal of oral science [Int J Oral Sci] 2024 Feb 18; Vol. 16 (1), pp. 13. Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*/genetics
Mouth Neoplasms*/pathology
Head and Neck Neoplasms*
Neoplasms, Multiple Primary*/genetics
Female ; Humans ; Lymphatic Metastasis/genetics ; Phylogeny ; Neoplasm Recurrence, Local ; Squamous Cell Carcinoma of Head and Neck ; Genomics
Czasopismo naukowe
Tytuł:
Exon-specific oncogenic function of the long noncoding RNA plasmacytoma variant translocation 1 in cutaneous squamous cell carcinoma: a promising potential therapeutic target.
Autorzy:
Bone M; Cancer Research UK Scotland Institute and School of Cancer Sciences, University of Glasgow, Glasgow, UK.
Inman GJ; Cancer Research UK Scotland Institute and School of Cancer Sciences, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło:
The British journal of dermatology [Br J Dermatol] 2024 Feb 16; Vol. 190 (3), pp. 300-301.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
RNA, Long Noncoding*/genetics
Plasmacytoma*/genetics
Skin Neoplasms*/drug therapy
Skin Neoplasms*/genetics
Humans ; Cell Line, Tumor ; Exons
Opinia redakcyjna
Tytuł:
Top 10 research priorities for cutaneous squamous cell carcinoma: results of the Skin Investigation Network of Canada Priority Setting Initiative.
Autorzy:
Lefrançois P; Division of Dermatology, Department of Medicine, McGill University, Montréal, QC, Canada.
Doueidari Z; Division of Dermatology, Department of Medicine, McGill University, Montréal, QC, Canada.
Kleiner O
Manion R
Dutz J
Philip A
Chan AW
Pokaż więcej
Corporate Authors:
Skin Investigation Network of Canada Priority Setting Collaborative
Źródło:
The British journal of dermatology [Br J Dermatol] 2024 Feb 16; Vol. 190 (3), pp. 431-432.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/epidemiology
Carcinoma, Squamous Cell*/therapy
Skin Neoplasms*/diagnosis
Skin Neoplasms*/epidemiology
Skin Neoplasms*/therapy
Biomedical Research*
Humans ; Canada/epidemiology ; Health Priorities
Czasopismo naukowe
Tytuł:
Lingual Denervation Improves the Efficacy of Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinomas by Downregulating TGFβ Signaling.
Autorzy:
Tao ZY; Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong.
Wang L; Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong.
Zhu WY; Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong.
Zhang G; Division of Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong, Hong Kong.
Su YX; Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong.
Pokaż więcej
Źródło:
Cancer research communications [Cancer Res Commun] 2024 Feb 15; Vol. 4 (2), pp. 418-430.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/immunology
Carcinoma, Squamous Cell*/therapy
Mouth Neoplasms*/immunology
Mouth Neoplasms*/therapy
Animals ; Mice ; B7-H1 Antigen/metabolism ; Denervation ; Immunotherapy ; Transforming Growth Factor beta/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł:
CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
Autorzy:
Hou Z; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, China.
Wu C; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, China.
Tang J; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, China.
Liu S; Department of Oral and Maxillofacial Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China. Electronic address: .
Li L; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, China. Electronic address: .
Pokaż więcej
Źródło:
Experimental cell research [Exp Cell Res] 2024 Feb 15; Vol. 435 (2), pp. 113935. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*/genetics
Mouth Neoplasms*/pathology
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Wnt Signaling Pathway/physiology ; beta Catenin/genetics ; beta Catenin/metabolism ; Cell Proliferation ; Glycolysis ; Cell Movement ; Lactates ; Glucose ; Cell Line, Tumor ; Adaptor Proteins, Signal Transducing/metabolism
Czasopismo naukowe
Tytuł:
The analysis of multiple omics and examination of pathological images revealed the prognostic and therapeutic significances of CD93 in lung squamous cell carcinoma.
Autorzy:
Qu J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong, China.
Lin L; Department of Respiratory Medicine, Shandong Provincial Chest Hospital, Shandong Public Health Clinical Center, Jinan 250117, Shandong, China.
Fu G; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266003, China.
Zheng M; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong, China.
Geng J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong, China.
Sun X; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, Shandong, China. Electronic address: .
Xing L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan 250117, Shandong, China. Electronic address: .
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2024 Feb 15; Vol. 339, pp. 122422. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Lung ; Prognosis
Czasopismo naukowe
Tytuł:
Frequency and functional characterization of fusion genes in squamous cell carcinoma of the lung.
Autorzy:
Alidousty C; University Hospital and Medical Faculty, University of Cologne, Institute of Pathology, Kerpener Straße 62, 50937 Cologne, Germany; Network Genomic Medicine, Cologne, Germany.
Becker A; University Hospital and Medical Faculty, University of Cologne, Institute of Pathology, Kerpener Straße 62, 50937 Cologne, Germany.
Binot E; University Hospital and Medical Faculty, University of Cologne, Institute of Pathology, Kerpener Straße 62, 50937 Cologne, Germany.
Hillmer AM; University Hospital and Medical Faculty, University of Cologne, Institute of Pathology, Kerpener Straße 62, 50937 Cologne, Germany; Network Genomic Medicine, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Robert Koch Strasse 21, 50931 Cologne, Germany.
Merkelbach-Bruse S; University Hospital and Medical Faculty, University of Cologne, Institute of Pathology, Kerpener Straße 62, 50937 Cologne, Germany; Network Genomic Medicine, Cologne, Germany.
Budde B; Cologne Center for Genomics, Medical Faculty of the University of Cologne, Weyertal 115b, 50931 Cologne, Germany.
Bäßmann I; Cologne Center for Genomics, Medical Faculty of the University of Cologne, Weyertal 115b, 50931 Cologne, Germany.
Rappl G; Center for Molecular Medicine Cologne, University of Cologne, Robert Koch Strasse 21, 50931 Cologne, Germany.
Wolf J; Lung Cancer Group Cologne, Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany.
Eich ML; University Hospital and Medical Faculty, University of Cologne, Institute of Pathology, Kerpener Straße 62, 50937 Cologne, Germany.
Noh KW; University Hospital and Medical Faculty, University of Cologne, Institute of Pathology, Kerpener Straße 62, 50937 Cologne, Germany.
Buettner R; University Hospital and Medical Faculty, University of Cologne, Institute of Pathology, Kerpener Straße 62, 50937 Cologne, Germany; Network Genomic Medicine, Cologne, Germany; Lung Cancer Group Cologne, Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany.
Schultheis AM; University Hospital and Medical Faculty, University of Cologne, Institute of Pathology, Kerpener Straße 62, 50937 Cologne, Germany. Electronic address: .
Pokaż więcej
Źródło:
Gene [Gene] 2024 Feb 15; Vol. 895, pp. 148018. Date of Electronic Publication: 2023 Nov 18.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Humans ; Anaplastic Lymphoma Kinase/genetics ; Proto-Oncogene Proteins/genetics ; Lung/pathology ; ErbB Receptors/genetics ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe
Tytuł:
SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification.
Autorzy:
Huang J; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China.
Li H; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China.
Yang Z; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China.
Liu R; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China.
Li Y; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China.
Hu Y; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China.
Zhao S; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China.
Gao X; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China.
Yang X; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China. .
Wei J; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral & Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China. .
Pokaż więcej
Źródło:
Cell death & disease [Cell Death Dis] 2024 Feb 14; Vol. 15 (2), pp. 139. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/radiotherapy
Carcinoma, Squamous Cell*/metabolism
Mouth Neoplasms*/genetics
Mouth Neoplasms*/radiotherapy
Mouth Neoplasms*/metabolism
Head and Neck Neoplasms*/metabolism
Adenine/*analogs & derivatives
Humans ; beta Catenin/genetics ; beta Catenin/metabolism ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Squamous Cell Carcinoma of Head and Neck/metabolism ; Cell Line, Tumor ; Neoplasm Recurrence, Local/pathology ; Methyltransferases/genetics ; Methyltransferases/metabolism ; Cell Proliferation/genetics ; Neoplastic Stem Cells/metabolism ; Transcription Factors/genetics ; Transcription Factors/metabolism
Czasopismo naukowe
Tytuł:
Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
Autorzy:
Zhang Q; Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University, Beijing, China. .
Li Y; Acornmed Biotechnology Co. Ltd, Beijing, China.
Zhang Y; Acornmed Biotechnology Co. Ltd, Beijing, China.
Deng Z; Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University, Beijing, China. .
Ding Y; Department of Pathology, Beijing Jishuitan Hospital, Peking University, Beijing, China. jst_.
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Feb 09; Vol. 22 (1), pp. 50. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Penile Neoplasms*/genetics
Penile Neoplasms*/therapy
Penile Neoplasms*/pathology
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/therapy
Carcinoma, Squamous Cell*/pathology
Male ; Humans ; Aged ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Neoplasm Recurrence, Local ; Mutation
Czasopismo naukowe
Tytuł:
LncRNA WWTR1-AS1 upregulates Notch3 through miR-136 to increase cancer cell stemness in cervical squamous cell carcinoma.
Autorzy:
Zhou X; Department of Obstetrics and Gynecology, Bishan hospital of Chongqing medical university, Bishan Hospital of Chongqing, No. 9 Shuangxing Avenue, Biquan Street, Bishan District, 402760, Chongqing City, P. R. China.
Li Z; Department of Obstetrics and Gynecology, Bishan hospital of Chongqing medical university, Bishan Hospital of Chongqing, No. 9 Shuangxing Avenue, Biquan Street, Bishan District, 402760, Chongqing City, P. R. China.
Li M; Department of Obstetrics and Gynecology, Bishan hospital of Chongqing medical university, Bishan Hospital of Chongqing, No. 9 Shuangxing Avenue, Biquan Street, Bishan District, 402760, Chongqing City, P. R. China. .
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2024 Feb 08; Vol. 24 (1), pp. 104. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
MicroRNAs*/genetics
RNA, Long Noncoding*/genetics
Uterine Cervical Neoplasms*/pathology
Female ; Humans ; Transcriptional Coactivator with PDZ-Binding Motif Proteins ; RNA, Antisense/genetics
Czasopismo naukowe
Tytuł:
A lesion in two: Buruli ulcer and squamous cell carcinoma coexistence.
Autorzy:
O'Keeffe JC; Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia.; Barwon South West Public Health Unit, Geelong, Victoria, Australia.
Yin AH; Department of Anatomical Pathology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
O'Brien DP; Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia.; Barwon South West Public Health Unit, Geelong, Victoria, Australia.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Feb 08; Vol. 18 (2), pp. e0011911. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Buruli Ulcer*/therapy
Carcinoma, Squamous Cell*/complications
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/pathology
Skin Neoplasms*/complications
Skin Neoplasms*/diagnosis
Male ; Humans ; Aged ; Health Personnel ; Australia
Czasopismo naukowe
Tytuł:
Case report: Clinical complete response in advanced ALK-positive lung squamous cell carcinoma: a case study of successful anti-PD-1 immunotherapy post ALK-TKIs failure.
Autorzy:
Yang C; Zhongshan City People's Hospital, Xinxiang Medical University, Xinxiang, China.; Department of Radiotherapy, Zhongshan City People's Hospital, Zhongshan, China.
Zeng R; Department of Radiotherapy, Zhongshan City People's Hospital, Zhongshan, China.
Zha Y; Department of Radiotherapy, Zhongshan City People's Hospital, Zhongshan, China.
Li Y; Department of Radiotherapy, Zhongshan City People's Hospital, Zhongshan, China.
Wang T; Department of Radiotherapy, Zhongshan City People's Hospital, Zhongshan, China.
Zhao R; Department of Imaging, Zhongshan City People's Hospital, Zhongshan, China.
Li M; Department of Radiotherapy, Zhongshan City People's Hospital, Zhongshan, China.
Zhang J; Department of Radiotherapy, Zhongshan City People's Hospital, Zhongshan, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 06; Vol. 15, pp. 1360671. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).
Typ publikacji:
Case Reports
MeSH Terms:
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Antineoplastic Agents*/therapeutic use
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Adenocarcinoma of Lung*/drug therapy
Humans ; Anaplastic Lymphoma Kinase/genetics ; Anaplastic Lymphoma Kinase/metabolism ; Protein-Tyrosine Kinases ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Immunotherapy ; Lung/pathology
Raport
Tytuł:
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.
Autorzy:
McLean LS; Peter MacCallum Cancer Centre, Melbourne, VIC.; The University of Melbourne, Melbourne, VIC.
Lim AM; Peter MacCallum Cancer Centre, Melbourne, VIC.; The University of Melbourne, Melbourne, VIC.
Bressel M; The University of Melbourne, Melbourne, VIC.; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, VIC.
Lee J; Chris O'Brien Lifehouse, Sydney, NSW.; Macquarie University, Sydney, NSW.
Ladwa R; Princess Alexandra Hospital, Brisbane, QLD.; The University of Queensland, Brisbane, QLD.
Guminski AD; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW.
Hughes B; The University of Queensland, Brisbane, QLD.; Royal Brisbane and Women's Hospital, Brisbane, QLD.
Bowyer S; Sir Charles Gairdner Hospital, Perth, WA.
Briscoe K; Mid North Coast Cancer Institute, Coffs Harbour, NSW.
Harris S; Bendigo Cancer Centre, Bendigo Health, Bendigo, VIC.
Kukard C; Central Coast Cancer Centre, Gosford, NSW.
Zielinski R; Central West Cancer Care Centre, Orange, NSW.; Western Sydney University, Penrith, NSW.
Alamgeer M; Monash Health, Melbourne, VIC.; Monash University, Melbourne, VIC.
Carlino M; Melanoma Institute Australia, Westmead and Blacktown Hospitals, Sydney, NSW.; The University of Sydney, Sydney, NSW.
Mo J; Westmead Hospital, Sydney, NSW.
Park JJ; Nepean Cancer Care Centre, Penrith, NSW.
Khattak MA; Fiona Stanley Hospital, Perth, WA.; Edith Cowan University, Perth, WA.
Day F; Calvary Mater Newcastle, Newcastle, NSW.
Rischin D; Peter MacCallum Cancer Centre, Melbourne, VIC.; The University of Melbourne, Melbourne, VIC.
Pokaż więcej
Źródło:
The Medical journal of Australia [Med J Aust] 2024 Feb 05; Vol. 220 (2), pp. 80-90. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Skin Neoplasms*/drug therapy
Skin Neoplasms*/pathology
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/pathology
Male ; Adult ; Humans ; Aged ; Female ; Retrospective Studies ; Immune Checkpoint Inhibitors/therapeutic use ; Cohort Studies ; Australia/epidemiology
Czasopismo naukowe
Tytuł:
Systemic and Local Administration of a Dual-siRNA Complex Efficiently Inhibits Tumor Growth and Bone Invasion in Oral Squamous Cell Carcinoma.
Autorzy:
Ma P; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan China.
He M; Joint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, 475004 Kaifeng, China.
Lian H; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan China.
Li J; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province China.
Gao Y; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province China.
Wu J; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province China.
Men K; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province China.
Men Y; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan China.
Li C; State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan China.
Pokaż więcej
Źródło:
Molecular pharmaceutics [Mol Pharm] 2024 Feb 05; Vol. 21 (2), pp. 661-676. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/therapy
Mouth Neoplasms*/genetics
Mouth Neoplasms*/therapy
Head and Neck Neoplasms*
Quaternary Ammonium Compounds*
Fatty Acids, Monounsaturated*
Mice ; Animals ; Micelles ; RNA, Small Interfering/genetics ; Squamous Cell Carcinoma of Head and Neck ; Polyethylene Glycols ; Polyesters ; Cell Line, Tumor
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies